BridgeMD
A clinical trial investigating Tranexamic Acid use in hind and midfoot arthrodesis surgery
EU CTIS ID: 2026-526142-27-01
What this study is testing
To evaluate the effect of intraoperative tranexamic acid on postoperative infection rates after mid- and hindfoot arthrodesis at one year
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age ≥ 18 years
- A foot and ankle orthopedic surgeon has determined that the patient is suitable for a hind- or midfoot arthrodesis procedure
- Ability to understand trial information and answer outcome assessments in Finnish or in Swedish
You likely can't join if
- Acute trauma
- Documented hypercoagulable disorder (inherited or acquired)
- History of seizures
- History of local bone or joint infection in the past 12 months
- Active bacterial infection or ulcer of the lower limb
- Diabetes mellitus and glycohaemoglobin (GHb-A1C > 64mmol/l)
See the full eligibility criteria
- Age ≥ 18 years
- A foot and ankle orthopedic surgeon has determined that the patient is suitable for a hind- or midfoot arthrodesis procedure
- Ability to understand trial information and answer outcome assessments in Finnish or in Swedish
- Acute trauma
- Documented hypercoagulable disorder (inherited or acquired)
- History of seizures
- History of local bone or joint infection in the past 12 months
- Active bacterial infection or ulcer of the lower limb
- Diabetes mellitus and glycohaemoglobin (GHb-A1C > 64mmol/l)
- Patients with severe circulatory disorder of the lower limb, absence of palpable pulses in the foot
- Patient unable to provide consent
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.